Involvement of norepinephrine in transmission of the stimulatory influence of progesterone on gonadotropin release.
D000818:Animals; D002219:Carbamates / Q000494:pharmacology; D002395:Catecholamines / Q000502:physiology; D002396:Catechols / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D005640:Follicle Stimulating Hormone / Q000097:blood*; D006220:Haloperidol / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000097:blood*; D008781:Methyltyrosines / Q000494:pharmacology; D009638:Norepinephrine / Q000096:biosynthesis / Q000502:physiology*; D010088:Oxidoreductases / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011374:Progesterone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D012694:Serine / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology; D013997:Time Factors
D002219:Carbamates; D002395:Catecholamines; D002396:Catechols; D002614:Chelating Agents; D008781:Methyltyrosines; D010643:Phenoxybenzamine; D012701:Serotonin; D012694:Serine; D011374:Progesterone; D004958:Estradiol; D004295:Dihydroxyphenylalanine; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D011433:Propranolol; D010088:Oxidoreductases; D006220:Haloperidol; D010134:Fenclonine; D004298:Dopamine; D009638:Norepinephrine